Functional Parameters Indicative of Heart Failure.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-18

Study Completion Date

2024-05-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study aims to validate the kinematic analysis obtained by two motion capture instruments for the functional objective assessment of elderly patients with Heart Failire (HF) and to develop a new functional index formed by kinematic parameters and other functional objective parameters and scales which may be impaired in patients with HF and they could allow the stratification of these patients based on different levels of functional impairment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

CR: Developing an Intervention to Improve Acceptance of Referral in HF

NCT04276675

Heart Failure Frailty

COMPLETED

Pathophysiological Mechanisms of Activity-Related Dyspnea in Heart Failure: A Pilot Study

NCT02007486

Heart Failure

UNKNOWN

A Hemodynamically Oriented Echocardiography-Based Strategy in the Treatment of Congestive Heart Failure

NCT00280254

Heart Failure

TERMINATED PHASE2

Heart Failure STratification and OutcomeS

NCT02444676

HEART FAILURE

COMPLETED

Interval Training in Heart Failure

NCT03955029

Chronic Heart Failure

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cardiovascular diseases carried on being the leading cause of disability due to noncommunicable diseases from 1990 to 2016. Within cardiovascular diseases, it has been estimated that heart failure (HF) has a prevalence in the population of approximately 2% to 3%. However, it is the only cardiovascular disease that is increasing in incidence and prevalence due to the aging of the world population, since the prevalence of this disease increases with age. Furthermore, heart failure represents the most important hospital diagnosis in older adults, being the main cause of hospital admissions for people older than 65 years and contributing to the increase of medical care costs.

Subjects with HF use to show a reduced aerobic capacity, a decreased muscle strength in the lower limbs, low weekly physical activity, intolerance to exercise and a lower walking speed than healthy subjects of the same age. In general, patients with heart failure have altered functional capacities and experience a decline in the ability to carry out activities of daily living and suffer a reduced quality of life. When it is assessed functional parameters in patients with heart failure, the maximum oxygen consumption (V0₂ max) obtained from a cardiopulmonary exercise test is considered the gold standard measure of cardiovascular functional capacity. Moreover, some functional tests have been used, such as the 6-Minute Walking Test, which provides an indirect measure of cardiovascular functional capacity, and the Short Physical Performance Battery (SPPB), which also provides a useful and indirect indication of muscle functional capacity. However, at the time of diagnosing or classifying patients with heart failure, the functional assessment does not use to be considered. The implementation of diagnostic guidelines or a functional assessment based on evidence can be important to improve prognosis and quality of life in patients with HF.

Therefore, there is a need to identify functional markers related to functionality that are indicative of heart failure. For this, it is necessary to use instruments to measure functional variables that must be valid and reliable, as established by the COSMIN taxonomy. Kinematic measurements allow quantifying normal and pathological movements, quantifying the degree of deterioration, planning rehabilitation strategies and evaluating the effect of various interventions. Inertial sensors and depth cameras are accurate and reliable methods for the kinematic analysis of human movement, in addition to presenting a good correlation of kinematic data between them.

Currently, it can be used the Simmer3 Inertial Sensor and 3D motion capture systems with a camera to analyse kinematics and these instruments are being integrated as a rehabilitation tool in patients. The use of Shimmer3 Inertial Sensor and 3D motion capture cameras would help to find fast and cheap assessment methods for professionals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Heart Failure

Heart Failure patients Subjects diagnosed with heart faikure, who will receive the best treatment of clinical practice, will be recruited. They must be more than 70 years old.

Group Type EXPERIMENTAL

Standard Care or Usual Clinical Practice

Intervention Type PROCEDURE

The guidelines for the management according to the heart failure in primary care will be the treatment guidelines for the Standard Care.

Healthy Subjects

Healthy Subjects/ Match control Healthy subjects of the same age as people with heart failure.

Group Type ACTIVE_COMPARATOR

Standard Care or Usual Clinical Practice

Intervention Type PROCEDURE

The guidelines for the management according to the heart failure in primary care will be the treatment guidelines for the Standard Care.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard Care or Usual Clinical Practice

The guidelines for the management according to the heart failure in primary care will be the treatment guidelines for the Standard Care.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects older than 70 years.
* Healthy subjects and subjects diagnosed with Heart failure.
* Subjects able of filling out questionnaires and performing functional tests.
* subjects who are in a clinical stability and optimal treatment phase.

Exclusion Criteria

* Participants with cardiac pathologies other than heart failure.
* Score in the NYHA scale equal to 4.
* Hospitalization in a period of time equal to or less than 3 months.
* Score on the Mini-Mental scale below 24.
* Inability to get up from the chair at least 5 times or 30 seconds.
* Inability to walk for 6 minutes.
* Inability to walk independently without a walking assistance device (cane, crutch or walker).
* Subjects participating in an experimental study where they receive a treatment.
* Inability to provide informed consent.

Minimum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes